Work

How does adding PD-(L)1 inhibitors to platinum-etoposide treatment of small cell lung cancer improve survival outcomes?

Year: 2026

Type: article

Abstract: 1. The introduction of immune checkpoint inhibitors (ICIs) targeting the PD-1/PD-L1 axis has improved survival outcomes in patients with both extensive stage (ES, 60-70% of cases) and limited stage...

Source: Expert Review of Anticancer Therapy

DOI: 10.1080/14737140.2026.2738624

Authors: Maria Giovanna Formelli, Adriana Di Odoardo, Elisa Andrini, Giuseppe Lamberti

Institution: University of Bologna

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W7213968064

FWCI:

Cites: 15

Cited by:

Related to: